Page last updated: 2024-08-25

ketorolac tromethamine and Mouth Neoplasms

ketorolac tromethamine has been researched along with Mouth Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Botlagunta, M; Das Majumdar, SK; Dash, R; Muduly, DK; Panda, S; Priyadarshini, M; Rath, R; Samal, SK; Shriwas, O1

Other Studies

1 other study(ies) available for ketorolac tromethamine and Mouth Neoplasms

ArticleYear
DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m
    Apoptosis : an international journal on programmed cell death, 2020, Volume: 25, Issue:3-4

    Topics: AlkB Homolog 5, RNA Demethylase; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cisplatin; DEAD-box RNA Helicases; Demethylation; Drug Resistance, Neoplasm; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Humans; Ketorolac Tromethamine; Mice; Mouth Neoplasms; Nanog Homeobox Protein; Neoplastic Stem Cells; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck; Tumor Burden; Xenograft Model Antitumor Assays

2020